康惠制药(603139)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603139 康惠制药

已收盘 08-15 15:00:00

{"stockData":{"symbol":"603139","market":"SH","secType":"STK","nameCN":"康惠制药","latestPrice":22.72,"timestamp":1755241201000,"preClose":22.6,"halted":0,"volume":1452300,"delay":0,"changeRate":0.0053,"floatShares":99880000,"shares":99880000,"eps":-1.0809,"marketStatus":"已收盘","change":0.12,"latestTime":"08-15 15:00:00","open":22.84,"high":22.88,"low":22.6,"amount":33011200,"amplitude":0.0124,"askPrice":22.73,"askSize":2,"bidPrice":22.72,"bidSize":42,"shortable":0,"etf":0,"ttmEps":-1.0809,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1755480600000},"marketStatusCode":5,"adr":0,"adjPreClose":22.6,"symbolType":"stock","openAndCloseTimeList":[[1755221400000,1755228600000],[1755234000000,1755241200000]],"highLimit":24.86,"lowLimit":20.34,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":99880000,"isCdr":false,"pbRate":2.7,"roa":"--","roe":"--","epsLYR":-0.9,"committee":0.156342,"marketValue":2269000000,"turnoverRate":0.0145,"status":0,"floatMarketCap":2269000000},"requestUrl":"/m/hq/s/603139","defaultTab":"news","newsList":[{"id":"2558394646","title":"长寿药NMN概念盘中拉升，翰宇药业涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558394646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558394646?lang=zh_cn&edition=full","pubTime":"2025-08-11 13:16","pubTimestamp":1754889418,"startTime":"0","endTime":"0","summary":"08月11日，长寿药NMN概念盘中拉升，截至13点16分，长寿药NMN概念整体指数上涨1.01%，报1238.740点。从个股上来看，该概念的成分股中，翰宇药业涨5.27%，兄弟科技、尔康制药、康惠制药涨幅居前。从资金上来看，截止发稿，长寿药NMN概念主力净流入为1364.05万，其中友阿股份受到资金热捧，主力净流入3181.15万；拉长时间线来看，该板块近20日主力资金净流入-43.71亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081113165897403111&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081113165897403111&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","603139","BK0070","BK0188","BK0239","BK0028","300199"],"gpt_icon":0},{"id":"2558500869","title":"每周股票复盘：康惠制药（603139）控股股东解除10510000股质押","url":"https://stock-news.laohu8.com/highlight/detail?id=2558500869","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558500869?lang=zh_cn&edition=full","pubTime":"2025-08-10 04:05","pubTimestamp":1754769914,"startTime":"0","endTime":"0","summary":"截至2025年8月8日收盘，康惠制药报收于22.86元，较上周的23.18元下跌1.38%。康惠控股已解除其所质押的公司股份10510000股，占其所持股份比例71.34%，占公司总股本比例10.52%，解除质押时间为2025年8月1日。目前，康惠控股及其一致行动人所持有的公司股份均不存在质押情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081000000775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603139","BK0239"],"gpt_icon":0},{"id":"2557515630","title":"中药企业股份转让潮：行业变革中的战略调整与资本动向","url":"https://stock-news.laohu8.com/highlight/detail?id=2557515630","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557515630?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:34","pubTimestamp":1754616896,"startTime":"0","endTime":"0","summary":"本次转让完成后，公司将不再持有宁波中药任何股份。华康股份表示，公司本次转让所持有宁波中药股份，是根据公司战略发展和实际经营情况对公司业务结构进一步优化和合理调整，不会影响公司生产经营正常运行，不会对公司的财务状况和经营成果造成重大影响，不存在损害上市公司及中小股东利益的情形。事实上，2025年以来，中药企业的股份转让并非华康股份这一例孤证。这些中药企业的股份转让行为，背后蕴含着复杂而多元的原因。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080809375794d6ad74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080809375794d6ad74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["562390","603139","605077","561510"],"gpt_icon":0},{"id":"2557557970","title":"康惠制药中标西安交大一附院项目 股价下跌1.9%成交额缩量","url":"https://stock-news.laohu8.com/highlight/detail?id=2557557970","media":"自选股中标信息","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557557970?lang=zh_cn&edition=full","pubTime":"2025-08-07 18:14","pubTimestamp":1754561677,"startTime":"0","endTime":"0","summary":"2025年08月07日，据天眼查数据，关于2025QT68 西安交通大学第一附属医院院内制剂委托申报加工项目院级磋商结果的公示显示，中标方为康惠制药，招标方为西安交通大学第一附属医院招标采供办公室。康惠制药主营业务涵盖医药流通，颗粒剂，片剂，其他收入之和。截至发稿，康惠制药股价报22.76元，下跌1.9%，成交额至4949.14万元。中标数据由天眼查提供，由程序或算法识别中标信息页面生成，可能与实际存在差异，不作为决策依据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807181444a6d88f3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807181444a6d88f3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2557462973","title":"中药行业盘中跳水，同仁堂跌0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557462973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557462973?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:55","pubTimestamp":1754445332,"startTime":"0","endTime":"0","summary":"08月06日，中药行业盘中跳水，截至09点55分，中药行业整体指数下跌1.02%，报6766.840点。从个股上来看，该行业的成分股中，同仁堂跌0.41%，云南白药、康惠制药、康缘药业跌幅居前。从资金上来看，截止发稿，中药行业主力净流入为-4.70亿，其中珍宝岛受到资金热捧，主力净流入953.19万；拉长时间线来看，该板块近20日主力资金净流入-17.98亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806095532a6d57fe6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806095532a6d57fe6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","LU1688375341.USD","BK0239","600085","BK0086","600557","BK0113","BK0196","BK0012","BK0097","BK0183","BK0028","603139"],"gpt_icon":0},{"id":"2557836071","title":"康惠制药中标西安市儿童医院项目 助力医药业务多元化发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2557836071","media":"自选股中标信息","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557836071?lang=zh_cn&edition=full","pubTime":"2025-08-05 18:18","pubTimestamp":1754389124,"startTime":"0","endTime":"0","summary":"2025年08月05日，据天眼查数据，西安市儿童医院中西医结合科固定方剂研发转化医院制剂项目成交结果公示显示，中标方为康惠制药，招标方为西安市儿童医院。康惠制药主营业务涵盖医药流通，颗粒剂，片剂，其他收入之和。截至发稿，康惠制药股价报23.21元，上涨1.49%，成交额至7717.45万元。股市有风险，请谨慎决策。中标数据由天眼查提供，由程序或算法识别中标信息页面生成，可能与实际存在差异，不作为决策依据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805181845a47664c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805181845a47664c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603139","BK0239","159938"],"gpt_icon":0},{"id":"2556802339","title":"康惠制药：康惠控股所持1051万股解除质押","url":"https://stock-news.laohu8.com/highlight/detail?id=2556802339","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556802339?lang=zh_cn&edition=full","pubTime":"2025-08-04 16:04","pubTimestamp":1754294660,"startTime":"0","endTime":"0","summary":"8月4日，公司收到康惠控股告知函，获悉康惠控股将其质押给华西证券股份有限公司的1051万股股份办理了解除质押手续。本次康惠控股解除其所质押的公司股份1051万股后，康惠控股及其一致行动人所持有的公司股份均不存在质押情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080416045797324b90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080416045797324b90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2556382183","title":"每周股票复盘：康惠制药（603139）为控股子公司提供500万元担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2556382183","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556382183?lang=zh_cn&edition=full","pubTime":"2025-08-03 06:35","pubTimestamp":1754174115,"startTime":"0","endTime":"0","summary":"截至2025年8月1日收盘，康惠制药报收于23.18元，较上周的22.8元上涨1.67%。本周，康惠制药8月1日盘中最高价报23.48元。本周关注点公司公告汇总：康惠制药为控股子公司春盛药业提供500万元连带责任保证担保公司公告汇总康惠制药为控股子公司四川春盛药业集团股份有限公司提供500万元连带责任保证担保。公司于2025年4月27日及5月20日召开董事会和股东大会，审议通过为控股子公司提供不超过19900万元的连带责任保证。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080300001191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2555098022","title":"康惠制药：为控股子公司春盛药业提供500万元担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2555098022","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555098022?lang=zh_cn&edition=full","pubTime":"2025-07-30 08:29","pubTimestamp":1753835360,"startTime":"0","endTime":"0","summary":"南财智讯7月30日电，康惠制药公告，为控股子公司四川春盛药业集团股份有限公司提供500万元人民币的连带责任保证担保，用于续贷。此次担保前后的担保余额均为2890万元，未超出2024年年度股东大会批准的担保限额。春盛药业的董事长骆春明及其一致行动人尹念娟为本次担保提供了反担保，反担保额为245万元。截至公告日，康惠制药及其控股子公司对外担保总额为11871.84万元，占公司最近一期经审计净资产的13.85%，无逾期担保。文章来源：南方财经网原标题：康惠制药：为控股子公司春盛药业提供500万元担保","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730084026972684a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730084026972684a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603139","BK0239"],"gpt_icon":0},{"id":"2553284223","title":"长寿药NMN概念盘中跳水，康惠制药跌0.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553284223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553284223?lang=zh_cn&edition=full","pubTime":"2025-07-22 14:08","pubTimestamp":1753164503,"startTime":"0","endTime":"0","summary":"07月22日，长寿药NMN概念盘中跳水，截至14点08分，长寿药NMN概念整体指数下跌1.01%，报1144.050点。从个股上来看，该概念的成分股中，康惠制药跌0.90%，百合股份、西王食品、晨光生物跌幅居前。从资金上来看，截止发稿，长寿药NMN概念主力净流入为-3.22亿，其中德展健康受到资金热捧，主力净流入4391.87万；拉长时间线来看，该板块近20日主力资金净流入-44.54亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722140823a6b9f423&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722140823a6b9f423&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603139","603102","BK0239"],"gpt_icon":0},{"id":"2552441066","title":"每周股票复盘：康惠制药（603139）预计2025年上半年亏损3800万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552441066","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552441066?lang=zh_cn&edition=full","pubTime":"2025-07-20 06:59","pubTimestamp":1752965948,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘，康惠制药报收于22.16元，较上周的22.65元下跌2.16%。本周，康惠制药7月14日盘中最高价报22.99元。7月15日盘中最低价报21.73元。康惠制药当前最新总市值22.13亿元，在中药板块市值排名65/67，在两市A股市值排名4907/5149。本周关注点业绩披露要点：康惠制药预计2025年1-6月归属净利润亏损约3800万元业绩披露要点康惠制药发布业绩预告，预计2025年1-6月归属净利润亏损约3800万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000001683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603139","BK0239"],"gpt_icon":0},{"id":"2551194958","title":"康惠制药股价下跌2.98% 公司涉股权回购纠纷进入二审阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2551194958","media":"金融界","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551194958?lang=zh_cn&edition=full","pubTime":"2025-07-16 03:31","pubTimestamp":1752607899,"startTime":"0","endTime":"0","summary":"截至2025年7月15日收盘，康惠制药股价报22.12元，较前一交易日下跌0.68元，跌幅2.98%。当日成交量为34663手，成交金额达0.77亿元。康惠制药是一家专注于中药研发、生产和销售的企业，公司产品涵盖多个治疗领域。公司所属行业板块包括中药、陕西板块等。公司近期公告显示，其与湖北科莱维的股权回购纠纷案件已进入二审阶段。此前一审判决要求科莱维向康惠制药支付定金200万元及股权回购款3599.40万元，并承担相应利息。目前上诉方已提交民事上诉状，案件仍在审理中。2025年7月15日，康惠制药主力资金净流入62.08万元，占流通市值的0.03%。风险提示：投资有风险，入市需谨慎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507160338119543d9b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507160338119543d9b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603139","BK0239"],"gpt_icon":0},{"id":"2551068185","title":"康惠制药：上半年预亏3800万元左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2551068185","media":"格隆汇资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551068185?lang=zh_cn&edition=full","pubTime":"2025-07-14 19:56","pubTimestamp":1752494209,"startTime":"0","endTime":"0","summary":"格隆汇7月14日丨康惠制药(603139.SH)公布2025年半年度业绩预告，预计2025年半年度实现归属于母公司所有者的净利润-3,800万元左右，将出现亏损。报告期内，公司非经常性损益影响金额约260万元，预计2025年半年度实现归属于母公司所有者的扣除非经常性损益后的净利润-4,100万元左右。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071419570097a5a35c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071419570097a5a35c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2551160589","title":"每周股票复盘：康惠制药（603139）股东减持及控制权拟变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2551160589","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551160589?lang=zh_cn&edition=full","pubTime":"2025-07-13 03:06","pubTimestamp":1752347169,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘，康惠制药报收于22.65元，较上周的23.37元下跌3.08%。康惠制药关于控股股东协议转让公司股份完成过户登记暨控制权拟发生变更的进展公告近日，康惠控股与悦合智创就本次股份转让已办理完成相关过户登记手续，过户日期为2025年7月8日。本次权益变动前后，康惠控股持股由36706237股降至14732637股，持股比例由36.75%降至14.75%；悦合智创持股增至21973600股，占公司总股本的22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300000504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2550299546","title":"华创医药投资观点&研究专题周周谈第134期：中药企业的创新布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2550299546","media":"华创证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550299546?lang=zh_cn&edition=full","pubTime":"2025-07-12 00:00","pubTimestamp":1752249600,"startTime":"0","endTime":"0","summary":"本周，中信医药指数上涨1.80%，跑赢沪深300指数0.98个百分点，在中信30个一级行业中排名第16位。本周涨幅前十名股票为前沿生物-U、美迪西、联环药业、康辰药业、启迪药业、华纳药厂、浩欧博、塞力医疗、福瑞股份、广生堂。本周跌幅前十名股票ST未名、神州细胞、舒泰神、一品红、海辰药业、华海药业、美诺华、永安药业、荣昌生物、创新医疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712112220a445eec5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712112220a445eec5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603567","603858","600993","600750","603998","600222","600976","600572","600557","600479","BK0239","600535","603439","603139","605199","600080","600252","159377","603896","600566","600285","600129","600594","399275","600436","600351","600771","600671","600332","600518"],"gpt_icon":0},{"id":"2550277025","title":"康惠制药股价微跌0.13% 股东拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2550277025","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550277025?lang=zh_cn&edition=full","pubTime":"2025-07-09 02:25","pubTimestamp":1751999110,"startTime":"0","endTime":"0","summary":"截至2025年7月8日15时，康惠制药股价报23.11元，较前一交易日下跌0.03元，跌幅0.13%。当日成交量为40553手，成交额达0.93亿元。康惠制药属于中药行业，公司主要从事中成药的研发、生产和销售。公司产品涵盖心脑血管、呼吸系统、消化系统等多个治疗领域。7月7日公司公告显示，持股4%的股东上海赛乐仙企业管理咨询有限公司计划自公告披露之日起15个交易日后三个月内，通过集中竞价及大宗交易方式减持不超过公司总股本3%的股份。2025年7月8日，康惠制药主力资金净流出111.74万元，占流通市值的0.05%。风险提示：股市有风险，投资需谨慎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709023238953b2821&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709023238953b2821&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2549381275","title":"康惠制药：赛乐仙拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2549381275","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549381275?lang=zh_cn&edition=full","pubTime":"2025-07-07 17:50","pubTimestamp":1751881844,"startTime":"0","endTime":"0","summary":"格隆汇7月7日丨康惠制药(603139.SH)公布，赛乐仙计划自本公告披露之日起十五个交易日后的三个月内，以集中竞价及大宗交易方式合计减持股份总数不超过299.64万股（即合计不超过公司股份总数的3%），减持价格依据市场价格确定。采取集中竞价交易方式减持公司股份的，任意连续90个自然日内，减持股份的总数不超过公司总股本的1%；采取大宗交易方式减持公司股份的，任意连续90个自然日内，减持股份的总数不超过公司总股本的2%；若此期间有送股、资本公积转增股本等股份变动事项，则对应数量进行相应调整。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707175101979ce241&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707175101979ce241&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2549432376","title":"每周股票复盘：康惠制药（603139）5%以上股东部分股权质押","url":"https://stock-news.laohu8.com/highlight/detail?id=2549432376","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549432376?lang=zh_cn&edition=full","pubTime":"2025-07-06 09:42","pubTimestamp":1751766133,"startTime":"0","endTime":"0","summary":"截至2025年7月4日收盘，康惠制药报收于23.37元，较上周的20.77元上涨12.52%。本周，康惠制药7月4日盘中最高价报24.5元。康惠制药当前最新总市值23.34亿元，在中药板块市值排名65/67，在两市A股市值排名4775/5149。本周关注点公司公告汇总：康惠制药持股5%以上股东扬州创响投资合伙企业质押1997600股公司公告汇总康惠制药关于持股5%以上股东部分股权质押的公告指出，持股5%以上的股东扬州创响投资合伙企业持有公司股份5992800股，占公司总股本的6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070600002388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2548980348","title":"康惠制药（603139）股东扬州创响投资合伙企业(有限合伙)质押199.76万股，占总股本2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548980348","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548980348?lang=zh_cn&edition=full","pubTime":"2025-07-03 18:22","pubTimestamp":1751538149,"startTime":"0","endTime":"0","summary":"证券之星消息，康惠制药7月3日公开信息显示，股东扬州创响投资合伙企业向杨茵合计质押199.76万股，占总股本2.0%。质押详情见下表：截止本公告日，股东陕西康惠控股有限公司已累计质押股份1051.0万股，占其持股总数的28.63%，股东扬州创响投资合伙企业已累计质押股份199.76万股，占其持股总数的33.33%。康惠制药主营业务：中成药的研发、生产、销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300031762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603139","BK0239"],"gpt_icon":0},{"id":"2548489840","title":"康惠制药涨5.07% 政策红利与业绩拐点构筑估值锚","url":"https://stock-news.laohu8.com/highlight/detail?id=2548489840","media":"智选洞察","labels":["policyRegulatory","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548489840?lang=zh_cn&edition=full","pubTime":"2025-07-03 09:57","pubTimestamp":1751507869,"startTime":"0","endTime":"0","summary":"康惠制药股价今日大幅上涨，最新价为22.59元/股，涨幅达5.07%。截至7月2日，康惠制药近5个交易日主力累计净流出超千万元，其中6月30日逆势净流入105万元后次日转为净流出109万元，资金流向反复折射市场分歧。政策红利与业绩拐点构筑估值锚产品储备与政策支持构成长期价值支撑。康惠制药291个药品批文中34个已纳入医保，中药配方颗粒备案制改革或带来增量空间，但2024年净利润亏损扩大至8962万元，连续三年亏损压制估值修复动能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703095800a72b9c4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703095800a72b9c4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603139","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1755334468983,"stockEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.1457},{"period":"6month","weight":0.5594},{"period":"1year","weight":0.8532},{"period":"ytd","weight":0.5822}],"compareEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":0.0551},{"period":"3month","weight":0.0978},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.2848},{"period":"ytd","weight":0.1029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"陕西康惠制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8739人(较上一季度增加13.43%)","perCapita":"11429股","listingDate":"2017-04-21","address":"陕西省咸阳市秦都区高新技术开发区彩虹二路","registeredCapital":"9988万元","survey":"　　陕西康惠制药股份有限公司的主营业务是中成药品的研究、开发、生产与销售。公司的主要产品是复方双花片、消银颗粒、坤复康胶囊、附桂骨痛胶囊、复方清带灌注液及芪药消渴胶囊。","listedPrice":14.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.8","shortVersion":"4.34.8","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康惠制药(603139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康惠制药(603139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康惠制药,603139,康惠制药股票,康惠制药股票老虎,康惠制药股票老虎国际,康惠制药行情,康惠制药股票行情,康惠制药股价,康惠制药股市,康惠制药股票价格,康惠制药股票交易,康惠制药股票购买,康惠制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康惠制药(603139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康惠制药(603139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}